Delivery Order SPE2DB22D3401-SPE2DB25FT5YV
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on August 13, 2025, valued at $1,201.20 for the supply of Trulicity 3 mg/0.5 ml pens (0.5 ml units). This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 14, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used to...
- The Defense Logistics Agency awarded a $13,827.64 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Trulicity 3 mg/0.5 ml pens with a completion date of August 5, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly utilized across military and federal healthcare systems. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $10,343.94 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pens on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a brand-name diabetes medication widely used in federal healthcare systems, including...
- The Defense Logistics Agency awarded a delivery order valued at $3,667.79 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pens on April 28, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by April 29, 2025, with performance to occur at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication used to improve blood sugar control in patients with type 2 diabetes,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 mL pens valued at $10,644.05 on September 2, 2025, with completion scheduled for September 3, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trulicity is a brand-name diabetes medication commonly used within military and veteran...
- The Defense Logistics Agency awarded a $2,366.00 delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 mL pens on July 28, 2025, with completion scheduled for July 29, 2025. This competitively awarded, firm fixed-price contract is unset-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly supplied through federal medical procurement channels to support military and veteran healthcare...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,628.25 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pens on August 4, 2025. This non-set-aside, firm fixed-price delivery order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 5, 2025. Trulicity is a brand-name diabetes medication commonly used within federal healthcare systems, including military and...
- The Defense Logistics Agency awarded a $6,044.85 delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 mL pens on September 16, 2025, with an ultimate completion date of September 17, 2025. This competitive award uses firm fixed pricing with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication used for glycemic control, consistent with AmerisourceBergen's extensive portfolio of...
- The Defense Logistics Agency awarded a $12,931.44 delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 mL pens on September 2, 2025, with an ultimate completion date of September 3, 2025. This is a firm fixed-price contract with no set-aside designation, reflecting a competitively awarded procurement. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. Trulicity is a diabetes medication used for treating type 2 diabetes,...
- The Defense Logistics Agency awarded a $3,003 delivery order to AmerisourceBergen Drug Corp for Trulicity 4.5 mg/0.5 ml pens on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price contract represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trulicity is a brand-name diabetes medication commonly used in military and veteran healthcare systems, aligning with the...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB25FT5YVDelivery Order
The Defense Logistics Agency awarded a $3,303.30 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Trulicity 3 mg/0.5 mL pens with a completion date of September 4, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used by military and veteran healthcare systems supported through the DLA's medical supply chain. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. This prime vehicle serves as a comprehensive global pharmaceutical support contract enabling AmerisourceBergen to supply a wide range of pharmaceutical products, specialty medications, vaccines, and medical supplies to support military healthcare programs worldwide. The contract reflects AmerisourceBergen's established capability as a major pharmaceutical distributor serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems through flexible delivery mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 9/3/25 |